Concepedia

Robert G. Perry

RG

9

Publications

918

Citations

9

H-Index

2006

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Elite Research Institute

Novartis (United States)

Novartis (India)

Robert G. Perry is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and liver physiology.

Top concepts

Publications per year

2006–2021

9

Publications

9

Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity

Steven B. Heymsfield, Laura A. Coleman, Ram R. Miller et al. · JAMA Network Open · 2021 · 259 citations · Full text

Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study

Daniel Rooks, Jens Præstgaard, Sam Hariry et al. · Journal of the American Geriatrics Society · 2017 · 215 citations

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial

Rohit Loomba, Rizwana Mohseni, Kathryn Jean Lucas et al. · Gastroenterology · 2021 · 204 citations · Full text

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults

Daniel Rooks, Therese Swan, Budhaditya Goswami et al. · JAMA Network Open · 2020 · 144 citations · Full text

Groundwater abstraction impacts on spring flow and base flow in the Hillsborough River Basin, Florida, USA

Kenneth A. Weber, Robert G. Perry · Hydrogeology Journal · 2006 · 30 citations

, , +8

Rows per page

1–5 of 9